Health Care Up as Eli Lilly Hits Record High - Health Care Roundup

Health-care companies rose as traders continued to pile into obesity-drug makers.

Eli Lilly shares tested record highs after the drugmaker released data from a late-stage Crohn's disease trial and struck a deal to develop new cancer-targeting medicines.

Shares of Eli Lilly's rival obesity-drug maker Novo Nordisk also rose.

Both companies have added rougly 35% in market value for the year to date because of the surge in popularity of the weigh-control injections.

Write to Rob Curran at [e-mail]

(END) Dow Jones Newswires

05-21-24 1750ET